Nuclear Radiology: Page 84

Covidien to move HQ to Ireland
By AuntMinnieEurope.com staff writers
The parent company of radiopharmaceutical firm Covidien has set in motion plans to incorporate in Ireland and relocate its executive office from Hamilton, Bermuda.
January 6, 2009
PET-based F-18 FLT equivocal for leukemia imaging
By Wayne Forrest
Researchers in Germany and the U.S. hoped that switching radiopharmaceuticals from FDG might improve PET's performance for imaging leukemia. While they found some benefits to using the new tracer, they also discovered some shortcomings.
January 6, 2009
Medrad sponsors Swiss PET project
By AuntMinnieEurope.com staff writers
Contrast injector technology firm Medrad signed a research agreement with the University of Zurich to study dynamic PET imaging with the Medrad Intego PET infusion system.
January 5, 2009
SPECT/CT outdoes planar imaging with lymph nodes
By Wayne Forrest
A newly released study in this month's issue of the Journal of Nuclear Medicine has found that SPECT/CT is better than planar imaging in accurately determining lymph node involvement at radioablation performed for thyroid cancer.
January 4, 2009
2009 01 02 10 59 03 130 Spect Planar Thumb
NRG reactor will be down longer
By AuntMinnieEurope.com staff writers
The Nuclear Research and Consultancy Group reactor in the Netherlands will be shut down beyond the anticipated February 2009 start-up date.
December 21, 2008
IBA gets FDA nod for pencil-beam scanning
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has received clearance from the U.S. Food and Drug Administration for its pencil-beam scanning treatment option for proton therapy.
December 18, 2008
FDG-PET/CT recommended for staging Hodgkin's disease
By Wayne Forrest
A British study confirms the high sensitivity and specificity of PET/CT in identifying focal bony disease in patients with Hodgkin's disease, according to research presented at the recent 2008 RSNA meeting. The results further suggest that the imaging modality can play an important role in initial staging of the disease.
December 18, 2008
IBA opens Dallas PET facility
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has opened a new PET radiopharmaceutical production facility in Dallas.
December 16, 2008
IBA responds to FDA warning letter
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has responded to a warning letter from the U.S. Food and Drug Administration related to manufacturing practices for PET radiotracers at a facility in Virginia.
December 10, 2008
IBA opens production center in Dallas
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) is opening a new PET radiopharmaceutical production facility in Dallas, the company announced.
December 1, 2008
IBA's interim Q3 report shows mixed results
By AuntMinnieEurope.com staff writers
Sales are up more than 50% for the first nine months of 2008 for radiopharmaceutical firm Ion Beam Applications (IBA), but the bottom line is expected to take a hit.
November 18, 2008
Dual-time-point FDG-PET/CT improves breast imaging accuracy
By Kate Madden Yee
Recent study results suggest that dual-time-point imaging with acquisition in the prone position improves PET/CT accuracy in patients with suspected breast cancer over single-time-point PET/CT. However, for lesions smaller than 10 mm, MRI shows higher sensitivity and should be preferred, according to the researchers.
November 17, 2008
2008 11 17 15 20 23 842 Figure4 B Thumb
Previous Page
Page 84 of 90
Next Page